{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:25:31Z","timestamp":1771489531840,"version":"3.50.1"},"reference-count":84,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2016YFA0501703"],"award-info":[{"award-number":["2016YFA0501703"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61832019, 61503244"],"award-info":[{"award-number":["61832019, 61503244"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the State Key Lab of Microbial Metabolism and Joint Research Funds for Medical and Engineering and Scientific Research at Shanghai Jiao Tong University","award":["(YG2017ZD14)"],"award-info":[{"award-number":["(YG2017ZD14)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Pyrazinamide (PZA) is the only drug for the elimination of latent Mycobacterium tuberculosis (MTB) isolates. However, due to the increased number of PZA-resistance, the chances of the success of global TB elimination seems to be more prolonged. Recently, marine natural products (MNPs) as an anti-TB agent have received much attention, where some compounds extracted from marine sponge, Haliclona sp. exhibited strong activity under aerobic and hypoxic conditions. In this study, we screened articles from 1994 to 2019 related to marine natural products (MNPs) active against latent MTB isolates. The literature was also mined for the major regulators to map them in the form of a pathway under the dormant stage. Five compounds were found to be more suitable that may be applied as an alternative to PZA for the better management of resistance under latent stage. However, the mechanism of actions behind these compounds is largely unknown. Here, we also applied synthetic biology to analyze the major regulatory pathway under latent TB that might be used for the screening of selective inhibitors among marine natural products (MNPs). We identified key regulators of MTB under latent TB through extensive literature mining and mapped them in the form of regulatory pathway, where SigH is negatively regulated by RshA. PknB, RshA, SigH, and RNA polymerase (RNA-pol) are the major regulators involved in MTB survival under latent stage. Further studies are needed to screen MNPs active against the main regulators of dormant MTB isolates. To reduce the PZA resistance burden, understanding the regulatory pathways may help in selective targets of MNPs from marine natural sources.<\/jats:p>","DOI":"10.3390\/md17100549","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T03:03:15Z","timestamp":1569553395000},"page":"549","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Marine Natural Products and Drug Resistance in Latent Tuberculosis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-2133","authenticated-orcid":false,"given":"Muhammad Tahir","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad 44000, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman Chandra","family":"Kaushik","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamer Iqbal","family":"Bhatti","sequence":"additional","affiliation":[{"name":"Department of Electrical Engineering, Capital University of Science and Technology, Islamabad 44000, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Juan","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Chongqing Normal University, Chongqing 401331, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie Jinghua","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaukat Iqbal","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad 44000, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-7502","authenticated-orcid":false,"given":"Dong Qing","family":"Wei","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"ref_1","unstructured":"WHO (2019, September 06). Global Tuberculosis Report 2017. Available online: http:\/\/apps.who.int\/medicinedocs\/en\/m\/abstract\/Js23360en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1038\/emi.2016.10","article-title":"Updates on the risk factors for latent tuberculosis reactivation and their managements","volume":"5","author":"Ai","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.drudis.2011.12.013","article-title":"Understanding latent tuberculosis: The key to improved diagnostic and novel treatment strategies","volume":"17","author":"Esmail","year":"2012","journal-title":"Drug Discov. Today"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Houben, R.M.G.J., and Dodd, P.J. (2016). The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002152"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tube.2015.05.017","article-title":"Tuberculosis: A disease without boundaries","volume":"95","author":"Fogel","year":"2015","journal-title":"Tuberculosis"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bruchfeld, J., Correia-Neves, M., and K\u00e4llenius, G. (2015). Tuberculosis and HIV Coinfection. Cold Spring Harb. Perspect. Med., 5.","DOI":"10.1101\/cshperspect.a017871"},{"key":"ref_7","first-page":"1433","article-title":"Tuberculosis in HIV\/AIDS Patients","volume":"69","author":"Fujita","year":"2017","journal-title":"Nihon Rinsho"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mekonnen, D., Derbie, A., and Desalegn, E. (2015). TB\/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: A 4 years retrospective study. BMC Res. Notes, 8.","DOI":"10.1186\/s13104-015-1664-0"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Pawlowski, A., Jansson, M., Sk\u00f6ld, M., Rottenberg, M.E., and K\u00e4llenius, G. (2012). Tuberculosis and HIV Co-Infection. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002464"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1183\/09031936.00110210","article-title":"Clinical management of tuberculosis and HIV-1 co-infection","volume":"36","author":"Schutz","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tesfaye, B., Alebel, A., Gebrie, A., Zegeye, A., Tesema, C., and Kassie, B. (2018). The twin epidemics: Prevalence of TB\/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203986"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12539-016-0175-6","article-title":"Identification of Potential Antituberculosis Drugs Through Docking and Virtual Screening","volume":"10","author":"Anand","year":"2018","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12539-014-0188-y","article-title":"Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11","volume":"6","author":"Hosen","year":"2014","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12539-017-0257-0","article-title":"In Silico Drug Design of Thiolactomycin Derivatives Against Mtb-KasA Enzyme to Inhibit Multidrug Resistance of Mycobacterium tuberculosis","volume":"11","author":"Durairaj","year":"2019","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/JCM.00620-12","article-title":"Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: A role for pncA but not rpsA","volume":"50","author":"Alexander","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3201\/eid2303.161034","article-title":"pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia","volume":"23","author":"Allana","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1128\/AAC.02394-14","article-title":"Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis","volume":"58","author":"Aono","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Khan, M.T., Malik, S.I., Ali, S., Sheed Khan, A., Nadeem, T., Zeb, M.T., Masood, N., and Afzal, M.T. (2018). Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan. Microb. Drug Resist.","DOI":"10.1089\/mdr.2017.0234"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00111-09","article-title":"Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa","volume":"16","author":"Black","year":"2009","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"E5069","DOI":"10.1073\/pnas.1321205110","article-title":"Osmosensory signaling in Mycobacterium tuberculosis mediated by a eukaryotic-like Ser\/Thr protein kinase","volume":"110","author":"Hatzios","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1128\/JB.00978-10","article-title":"DosS responds to a reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon","volume":"192","author":"Honaker","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1073\/pnas.121172498","article-title":"Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin","volume":"98","author":"Sherman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1073\/pnas.0801143105","article-title":"Regulation of the SigH stress response regulon by an essential protein kinase in Mycobacterium tuberculosis","volume":"105","author":"Park","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Busche, T., \u0160ilar, R., Pi\u010dmanov\u00e1, M., P\u00e1tek, M., and Kalinowski, J. (2012). Transcriptional regulation of the operon encoding stress-responsive ECF sigma factor SigH and its anti-sigma factor RshA, and control of its regulatory network in Corynebacterium glutamicum. BMC Genom., 13.","DOI":"10.1186\/1471-2164-13-445"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1017\/S1462399411002079","article-title":"Redox homeostasis in mycobacteria: The key to tuberculosis control?","volume":"13","author":"Kumar","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-398264-3.00004-8","article-title":"Redox biology of tuberculosis pathogenesis","volume":"60","author":"Trivedi","year":"2012","journal-title":"Adv. Microb. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.meegid.2004.04.003","article-title":"The extracytoplasmic function sigma factors: Role in bacterial pathogenesis","volume":"4","author":"Bashyam","year":"2004","journal-title":"Infect. Genet. Evol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1128\/JB.181.14.4266-4274.1999","article-title":"A mycobacterial extracytoplasmic sigma factor involved in survival following heat shock and oxidative stress","volume":"181","author":"Fernandes","year":"1999","journal-title":"J. Bacteriol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2958.2003.03739.x","article-title":"RshA, an anti-sigma factor that regulates the activity of the mycobacterial stress response sigma factor SigH","volume":"50","author":"Song","year":"2003","journal-title":"Mol. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1128\/JB.183.20.6119-6125.2001","article-title":"The alternative sigma factor sigh regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis","volume":"183","author":"Raman","year":"2001","journal-title":"J. Bacteriol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11554","DOI":"10.1073\/pnas.96.20.11554","article-title":"Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS)","volume":"96","author":"Graham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1073\/pnas.102055799","article-title":"Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH","volume":"99","author":"Kaushal","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0041-3879(85)90040-6","article-title":"The action of antituberculosis drugs in short-course chemotherapy","volume":"66","author":"Mitchison","year":"1985","journal-title":"Tubercle"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/mmi.12892","article-title":"Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide","volume":"95","author":"Yang","year":"2015","journal-title":"Mol. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yadon, A.N., Maharaj, K., Adamson, J.H., Lai, Y.-P., Sacchettini, J.C., Ioerger, T.R., Rubin, E.J., and Pym, A.S. (2017). A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide. Nat. Commun., 8.","DOI":"10.1038\/s41467-017-00721-2"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1128\/AAC.00507-11","article-title":"Pyrazinoic Acid Decreases the Proton Motive Force, Respiratory ATP Synthesis Activity, and Cellular ATP Levels","volume":"55","author":"Lu","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jac\/dkg446","article-title":"Mode of action of pyrazinamide: Disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid","volume":"52","author":"Ying","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_39","unstructured":"Khan, M.T., and Malik, S.I. (2019). Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance. J. Biomol. Struct. Dyn., 1\u201315."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1002\/jcb.27989","article-title":"Pyrazinamide resistance and mutations L19R, R140H, and E144K in Pyrazinamidase of Mycobacterium tuberculosis","volume":"120","author":"Khan","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1038\/s41598-019-44013-9","article-title":"Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance","volume":"9","author":"Khan","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.csbj.2018.09.004","article-title":"Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance","volume":"16","author":"Khan","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Junaid, M., Khan, M.T., Malik, S.I., and Wei, D.Q. (2018). Insights into the mechanisms of pyrazinamide resistance of three pyrazinamidase mutants N11K, P69T and D126N. J. Chem. Inf. Model.","DOI":"10.1021\/acs.jcim.8b00525"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/acs.jcim.8b00956","article-title":"Exploring the Pyrazinamide Drug Resistance Mechanism of Clinical Mutants T370P and W403G in Ribosomal Protein S1 of Mycobacterium tuberculosis","volume":"59","author":"Rehman","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_45","first-page":"705","article-title":"Pyrazinamide-resistant mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa and rpsA mutations","volume":"32","author":"Khan","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural Products as Sources of New Drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/adt.2015.673","article-title":"Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents","volume":"14","author":"Farah","year":"2016","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4155\/fmc.11.118","article-title":"Marine natural products: A new wave of drugs?","volume":"3","author":"Montaser","year":"2011","journal-title":"Future Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"12512","DOI":"10.1002\/chem.201001279","article-title":"Antibacterials from the Sea","volume":"16","author":"Hughes","year":"2010","journal-title":"Chemistry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2019.01.026","article-title":"Marine natural products as potential anti-tubercular agents","volume":"165","author":"Hou","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e00743-17","DOI":"10.1128\/AAC.00743-17","article-title":"Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products","volume":"61","author":"Felix","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Dhar, N., McKinney, J., and Manina, G. (2016). Phenotypic Heterogeneity in Mycobacterium tuberculosis. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.TBTB2-0021-2016"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/md10081711","article-title":"Evaluation of pseudopteroxazole and pseudopterosin derivatives against Mycobacterium tuberculosis and other pathogens","volume":"10","author":"McCulloch","year":"2012","journal-title":"Mar. Drugs"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/md12041757","article-title":"Synthesis and anti-tuberculosis activity of the marine natural product caulerpin and its analogues","volume":"12","year":"2014","journal-title":"Mar. Drugs"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Bra\u00f1a, A.F., Sarmiento-Vizca\u00edno, A., P\u00e9rez-Victoria, I., Mart\u00edn, J., Otero, L., Palacios-Guti\u00e9rrez, J.J., Fern\u00e1ndez, J., Mohamedi, Y., Fontanil, T., and Salm\u00f3n, M. (2019). Desertomycin G, a New Antibiotic with Activity against Mycobacterium tuberculosis and Human Breast Tumor Cell Lines Produced by Streptomyces althioticus MSM3, Isolated from the Cantabrian Sea Intertidal Macroalgae Ulva sp.. Mar. Drugs, 17.","DOI":"10.3390\/md17020114"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1021\/np9900829","article-title":"Methanol adduct of puupehenone, a biologically active derivative from the marine sponge Hyrtios species","volume":"62","author":"Lacombe","year":"1999","journal-title":"J. Nat. Prod."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/np500793g","article-title":"Puupehenol, a potent antioxidant antimicrobial meroterpenoid from a Hawaiian deep-water Dactylospongia sp. sponge","volume":"78","author":"Hagiwara","year":"2015","journal-title":"J. Nat. Prod."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.3390\/md8122849","article-title":"Cytotoxic terpene quinones from marine sponges","volume":"8","author":"Gordaliza","year":"2010","journal-title":"Mar. Drugs"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.tet.2006.11.088","article-title":"Studies on puupehenone-metabolites of a Dysidea sp.: Structure and biological activity","volume":"63","author":"Ciavatta","year":"2007","journal-title":"Tetrahedron"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/np900465e","article-title":"Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes","volume":"72","author":"Robinson","year":"2009","journal-title":"J. Nat. Prod."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1073\/pnas.0500469102","article-title":"Inhibitors of type II NADH: Menaquinone oxidoreductase represent a class of antitubercular drugs","volume":"102","author":"Weinstein","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.gene.2014.08.024","article-title":"Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro","volume":"550","author":"Awasthy","year":"2014","journal-title":"Gene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1073\/pnas.0711697105","article-title":"The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.tet.2004.03.043","article-title":"Synthesis and antitubercular activity of tricyclic analogs of puupehenone","volume":"60","author":"Kraus","year":"2004","journal-title":"Tetrahedron"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1016\/S0040-4020(98)00473-6","article-title":"The haliclonacyclamines, cytotoxic tertiary alkaloids from the tropical marine sponge Haliclona sp.","volume":"54","author":"Clark","year":"1998","journal-title":"Tetrahedron"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1248\/cpb.57.1136","article-title":"Haliclonacyclamines, tetracyclic alkylpiperidine alkaloids, as anti-dormant mycobacterial substances from a marine sponge of Haliclona sp.","volume":"57","author":"Arai","year":"2009","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/jo00091a005","article-title":"A tetracyclic diamine alkaloid, halicyclamine A, from the marine sponge Haliclona sp.","volume":"59","author":"Jaspars","year":"1994","journal-title":"J. Org. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1016\/j.bmc.2008.05.061","article-title":"Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent","volume":"16","author":"Arai","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s004410051128","article-title":"A sponge\/dinoflagellate association in the haplosclerid sponge Haliclona sp.: Cellular origin of cytotoxic alkaloids by percoll density gradient fractionation","volume":"293","author":"Garson","year":"1998","journal-title":"Cell Tissue Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.bmcl.2010.07.084","article-title":"Neopetrosiamine A, biologically active bis-piperidine alkaloid from the Caribbean sea sponge Neopetrosia proxima","volume":"20","author":"Wei","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2958.2002.03005.x","article-title":"Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression","volume":"45","author":"Manganelli","year":"2002","journal-title":"Mol. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1574-6976.2010.00239.x","article-title":"Mechanisms for activating bacterial RNA polymerase","volume":"34","author":"Ghosh","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_76","unstructured":"Vuorre, M. (2018, October 09). Quantitative Literature Review with R: Exploring Psychonomic Society Journals, Part I. Available online: https:\/\/vuorre.netlify.com\/post\/2017\/quantitative-literature-review-with-r-part-i\/."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12038-015-9552-2","article-title":"pubmed.mineR: An R package with text-mining algorithms to analyse PubMed abstracts","volume":"40","author":"Rani","year":"2015","journal-title":"J. Biosci."},{"key":"ref_78","unstructured":"(2018, October 09). RISmed: Download Content from NCBI Databases Version 2.1.7 from CRAN. Available online: https:\/\/rdrr.io\/cran\/RISmed\/."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Larsen, K.G., Mikucionis, M., Nielsen, B., and Skou, A. (2005, January 18\u201322). Testing Real-time Embedded Software Using UPPAAL-TRON: An Industrial Case Study. Proceedings of the 5th ACM International Conference on Embedded Software 2005, Jersey City, NJ, USA.","DOI":"10.1145\/1086228.1086283"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: Quality-Controlled protein\u2013protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software Environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/npjsba.2016.2","article-title":"Pathways on demand: Automated reconstruction of human signaling networks","volume":"2","author":"Ritz","year":"2016","journal-title":"NPJ Syst. Biol. Appl."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Guerrieri, A., Loscri, V., Rovella, A., and Fortino, G. (2016). ANIMO, framework to simplify the real-time distributed communication. Management of Cyber Physical Objects in the Future Internet of Things, Springer.","DOI":"10.1007\/978-3-319-26869-9"},{"key":"ref_84","first-page":"5","article-title":"Logisim Operon Circuits","volume":"4","author":"Kaushik","year":"2013","journal-title":"IJSER"}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/17\/10\/549\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:35Z","timestamp":1760189075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/17\/10\/549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":84,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["md17100549"],"URL":"https:\/\/doi.org\/10.3390\/md17100549","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]}}}